Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer.
Clin Cancer Res
; 23(22): 6771-6780, 2017 Nov 15.
Article
in En
| MEDLINE
| ID: mdl-28855352
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
Colorectal Neoplasms
/
Antineoplastic Agents, Alkylating
/
Cyclophosphamide
/
Immunomodulation
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2017
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United States